Skip to main content
Top
Published in: BMC Immunology 1/2008

Open Access 01-12-2008 | Research article

Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals

Authors: Lisa Barrett, Maureen Gallant, Constance Howley, M Ian Bowmer, Geri Hirsch, Kevork Peltekian, Michael Grant

Published in: BMC Immunology | Issue 1/2008

Login to get access

Abstract

Background

Multiple immune evasion strategies by which HCV establishes chronic infection have been proposed, including manipulation of cytokine responses. Prior infection with HIV increases the likelihood of chronic HCV infection and accelerates development of HCV-related morbidity. Therefore, we investigated in vitro cytokine responses to HCV structural and non-structural proteins in peripheral blood mononuclear cells (PBMC) from uninfected, HIV-infected, HCV-infected and HIV/HCV-coinfected individuals.

Results

Intracellular flow cytometry was used to assess IL-2, IL-10, IL-12, and IFN-γ production by freshly isolated PBMC incubated for 16 hours with recombinant HCV core, non-structural protein 3 (NS3), and NS4 proteins. Anti-HCV cellular responses were assessed in HIV/HCV-coinfected individuals by 3H-thymidine proliferation assay. Exposure to HCV antigens increased IL-10 production by PBMC, especially in uninfected and HIV-monoinfected individuals. This IL-10 response was attenuated in chronic HCV infection even with HCV/HIV-coinfection. The cells producing IL-10 in response to HCV proteins in vitro matched a PBMC subset recently shown to constitutively produce IL-10 in vivo. This subset was found at similar frequencies in uninfected, HIV-infected, HCV-infected and HIV/HCV-coinfected individuals before exposure to HCV proteins. HCV-specific T cell proliferation was detectable in only one HIV/HCV-coinfected individual who demonstrated no HCV-induced IL-10 response.

Conclusion

This pattern suggests that selective induction of IL-10 in uninfected individuals and especially in HIV-monoinfected individuals plays a role in establishing chronic HCV infection and conversely, that attenuation of this response, once chronic infection is established, favours development of hepatic immunopathology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alcami A, Koszinowski U: Viral mechanisms of immune evasion. Immunol Today. 2000, 21: 447-455. 10.1016/S0167-5699(00)01699-6.CrossRefPubMed Alcami A, Koszinowski U: Viral mechanisms of immune evasion. Immunol Today. 2000, 21: 447-455. 10.1016/S0167-5699(00)01699-6.CrossRefPubMed
2.
go back to reference Finlay BB, McFadden G: Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell. 2006, 124: 767-782. 10.1016/j.cell.2006.01.034.CrossRefPubMed Finlay BB, McFadden G: Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell. 2006, 124: 767-782. 10.1016/j.cell.2006.01.034.CrossRefPubMed
3.
go back to reference Krauss O, Hollinshead R, Hollinshead M, Smith GL: An investigation of incorporation of cellular antigens into vaccinia virus particles. J Gen Virol. 2002, 83: 2347-2359.CrossRefPubMed Krauss O, Hollinshead R, Hollinshead M, Smith GL: An investigation of incorporation of cellular antigens into vaccinia virus particles. J Gen Virol. 2002, 83: 2347-2359.CrossRefPubMed
4.
go back to reference Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G: Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci USA. 1987, 84: 4567-4571. 10.1073/pnas.84.13.4567.PubMedCentralCrossRefPubMed Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G: Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci USA. 1987, 84: 4567-4571. 10.1073/pnas.84.13.4567.PubMedCentralCrossRefPubMed
5.
go back to reference Hoofnagle JH: Hepatitis C: the clinical spectrum of disease. Hepatology. 1997, 26: 15S-20S. 10.1002/hep.510260703.CrossRefPubMed Hoofnagle JH: Hepatitis C: the clinical spectrum of disease. Hepatology. 1997, 26: 15S-20S. 10.1002/hep.510260703.CrossRefPubMed
6.
go back to reference Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD: Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000, 191: 1499-1512. 10.1084/jem.191.9.1499.PubMedCentralCrossRefPubMed Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD: Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000, 191: 1499-1512. 10.1084/jem.191.9.1499.PubMedCentralCrossRefPubMed
7.
go back to reference Gruner NH, Gerlach TJ, Jung MC, Diepolder HM, Schirren CA, Schraut WW, Hoffmann R, Zachoval R, Santantonio T, Cucchiarini M, Cerny A, Pape GR: Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C . J Infect Dis. 2000, 181: 1528-1536. 10.1086/315450.CrossRefPubMed Gruner NH, Gerlach TJ, Jung MC, Diepolder HM, Schirren CA, Schraut WW, Hoffmann R, Zachoval R, Santantonio T, Cucchiarini M, Cerny A, Pape GR: Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C . J Infect Dis. 2000, 181: 1528-1536. 10.1086/315450.CrossRefPubMed
8.
go back to reference Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F, Ferrari C: Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest. 1996, 98: 706-714. 10.1172/JCI118842.PubMedCentralCrossRefPubMed Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F, Ferrari C: Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest. 1996, 98: 706-714. 10.1172/JCI118842.PubMedCentralCrossRefPubMed
9.
go back to reference Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV: Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001, 194: 1395-1406. 10.1084/jem.194.10.1395.PubMedCentralCrossRefPubMed Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV: Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001, 194: 1395-1406. 10.1084/jem.194.10.1395.PubMedCentralCrossRefPubMed
10.
go back to reference Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, Gandhi RT, Chung RT, Walker BD: Broad specificity of virus-specific CD4+ T-helper cell responses in resolved hepatitis C virus infection. J Virol. 2002, 76: 12584-12595. 10.1128/JVI.76.24.12584-12595.2002.PubMedCentralCrossRefPubMed Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, Gandhi RT, Chung RT, Walker BD: Broad specificity of virus-specific CD4+ T-helper cell responses in resolved hepatitis C virus infection. J Virol. 2002, 76: 12584-12595. 10.1128/JVI.76.24.12584-12595.2002.PubMedCentralCrossRefPubMed
11.
go back to reference Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, Zachoval R, Pape GR, Diepolder HM: Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C. Hepatology. 2003, 37: 1189-1198. 10.1053/jhep.2003.50194.CrossRefPubMed Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, Zachoval R, Pape GR, Diepolder HM: Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C. Hepatology. 2003, 37: 1189-1198. 10.1053/jhep.2003.50194.CrossRefPubMed
12.
go back to reference Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H, Rehermann B: Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol. 2002, 169: 3447-3458.CrossRefPubMed Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H, Rehermann B: Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol. 2002, 169: 3447-3458.CrossRefPubMed
13.
go back to reference Rahman F, Heller T, Sobao Y, Mizukoshi E, Nascimbeni M, Alter H, Herrine S, Hoofnagle J, Liang TJ, Rehermann B: Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology. 2004, 40: 87-97. 10.1002/hep.20253.CrossRefPubMed Rahman F, Heller T, Sobao Y, Mizukoshi E, Nascimbeni M, Alter H, Herrine S, Hoofnagle J, Liang TJ, Rehermann B: Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology. 2004, 40: 87-97. 10.1002/hep.20253.CrossRefPubMed
14.
go back to reference Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T: Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. Hum Immunol. 2003, 64: 497-504. 10.1016/S0198-8859(03)00041-7.CrossRefPubMed Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T: Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. Hum Immunol. 2003, 64: 497-504. 10.1016/S0198-8859(03)00041-7.CrossRefPubMed
15.
go back to reference Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS: Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem. 2004, 279: 43479-43486. 10.1074/jbc.M407640200.CrossRefPubMed Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS: Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem. 2004, 279: 43479-43486. 10.1074/jbc.M407640200.CrossRefPubMed
16.
go back to reference Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics L, Mandrekar P, Zapp M, Szabo G: Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 2003, 170: 5615-5624.CrossRefPubMed Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics L, Mandrekar P, Zapp M, Szabo G: Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 2003, 170: 5615-5624.CrossRefPubMed
17.
go back to reference Yao ZQ, Nguyen DT, Hiotellis AI, Hahn YS: Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol. 2001, 167: 5264-5272.CrossRefPubMed Yao ZQ, Nguyen DT, Hiotellis AI, Hahn YS: Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol. 2001, 167: 5264-5272.CrossRefPubMed
18.
go back to reference Khu YL, Tan YJ, Lim SG, Hong W, Goh PY: Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity. Biochem J. 2004, 384: 401-409. 10.1042/BJ20040858.PubMedCentralCrossRefPubMed Khu YL, Tan YJ, Lim SG, Hong W, Goh PY: Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity. Biochem J. 2004, 384: 401-409. 10.1042/BJ20040858.PubMedCentralCrossRefPubMed
19.
go back to reference Bartenschlager R, Lohmann V: Replication of hepatitis C virus. J Gen Virol. 2000, 81 (Pt 7): 1631-1648.CrossRefPubMed Bartenschlager R, Lohmann V: Replication of hepatitis C virus. J Gen Virol. 2000, 81 (Pt 7): 1631-1648.CrossRefPubMed
20.
go back to reference Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Moradpour D, Bienz K: Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol. 2002, 76: 5974-5984. 10.1128/JVI.76.12.5974-5984.2002.PubMedCentralCrossRefPubMed Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Moradpour D, Bienz K: Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol. 2002, 76: 5974-5984. 10.1128/JVI.76.12.5974-5984.2002.PubMedCentralCrossRefPubMed
21.
go back to reference Gale M, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG: Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol. 1998, 18: 5208-5218.PubMedCentralCrossRefPubMed Gale M, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG: Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol. 1998, 18: 5208-5218.PubMedCentralCrossRefPubMed
22.
go back to reference Barrett L, Dai C, Gamberg J, Gallant M, Grant M: Circulating CD14-CD36+ peripheral blood mononuclear cells constitutively produce interleukin-10. J Leukoc Biol. 2007, 82: 152-160. 10.1189/jlb.0806521.CrossRefPubMed Barrett L, Dai C, Gamberg J, Gallant M, Grant M: Circulating CD14-CD36+ peripheral blood mononuclear cells constitutively produce interleukin-10. J Leukoc Biol. 2007, 82: 152-160. 10.1189/jlb.0806521.CrossRefPubMed
23.
go back to reference Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM: Structural biology of hepatitis C virus. Hepatology. 2004, 39: 5-19. 10.1002/hep.20032.CrossRefPubMed Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM: Structural biology of hepatitis C virus. Hepatology. 2004, 39: 5-19. 10.1002/hep.20032.CrossRefPubMed
24.
go back to reference Pawlotsky JM: Virology of hepatitis B and C viruses and antiviral targets. J Hepatol. 2006, 44: S10-S13. 10.1016/j.jhep.2005.11.005.CrossRefPubMed Pawlotsky JM: Virology of hepatitis B and C viruses and antiviral targets. J Hepatol. 2006, 44: S10-S13. 10.1016/j.jhep.2005.11.005.CrossRefPubMed
25.
go back to reference Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G: Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol. 2006, 177: 6758-6768.CrossRefPubMed Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G: Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol. 2006, 177: 6758-6768.CrossRefPubMed
26.
go back to reference Aborsangaya KB, Dembinski I, Khatkar S, Alphonse MP, Nickerson P, Rempel JD: Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms. Hepatology. 2007, 45: 623-630. 10.1002/hep.21511.CrossRefPubMed Aborsangaya KB, Dembinski I, Khatkar S, Alphonse MP, Nickerson P, Rempel JD: Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms. Hepatology. 2007, 45: 623-630. 10.1002/hep.21511.CrossRefPubMed
27.
go back to reference Brady MT, MacDonald AJ, Rowan AG, Mills KH: Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol. 2003, 33: 3448-3457. 10.1002/eji.200324251.CrossRefPubMed Brady MT, MacDonald AJ, Rowan AG, Mills KH: Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol. 2003, 33: 3448-3457. 10.1002/eji.200324251.CrossRefPubMed
28.
go back to reference Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, et al, et al.: Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology. 2002, 122: 352-365. 10.1053/gast.2002.31001.CrossRefPubMed Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, et al, et al.: Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology. 2002, 122: 352-365. 10.1053/gast.2002.31001.CrossRefPubMed
29.
go back to reference Majumder B, Janket ML, Schafer EA, Schaubert K, Huang XL, Kan-Mitchell J, Rinaldo CR, Ayyavoo V: Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J Virol. 2005, 79: 7990-8003. 10.1128/JVI.79.13.7990-8003.2005.PubMedCentralCrossRefPubMed Majumder B, Janket ML, Schafer EA, Schaubert K, Huang XL, Kan-Mitchell J, Rinaldo CR, Ayyavoo V: Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J Virol. 2005, 79: 7990-8003. 10.1128/JVI.79.13.7990-8003.2005.PubMedCentralCrossRefPubMed
30.
go back to reference Gee K, Angel JB, Ma W, Mishra S, Gajanayaka N, Parato K, Kumar A: Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. J Biol Chem. 2006, 281: 31647-31658. 10.1074/jbc.M512109200.CrossRefPubMed Gee K, Angel JB, Ma W, Mishra S, Gajanayaka N, Parato K, Kumar A: Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. J Biol Chem. 2006, 281: 31647-31658. 10.1074/jbc.M512109200.CrossRefPubMed
31.
go back to reference Badou A, Bennasser Y, Moreau M, Leclerc C, Benkirane M, Bahraoui E: Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway. J Virol. 2000, 74: 10551-10562. 10.1128/JVI.74.22.10551-10562.2000.PubMedCentralCrossRefPubMed Badou A, Bennasser Y, Moreau M, Leclerc C, Benkirane M, Bahraoui E: Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway. J Virol. 2000, 74: 10551-10562. 10.1128/JVI.74.22.10551-10562.2000.PubMedCentralCrossRefPubMed
32.
go back to reference Tangsinmankong N, Day NK, Good RA, Haraguchi S: Monocytes are target cells for IL-10 induction by HIV-1 Nef protein. Cytokine. 2000, 12: 1506-1511. 10.1006/cyto.2000.0741.CrossRefPubMed Tangsinmankong N, Day NK, Good RA, Haraguchi S: Monocytes are target cells for IL-10 induction by HIV-1 Nef protein. Cytokine. 2000, 12: 1506-1511. 10.1006/cyto.2000.0741.CrossRefPubMed
33.
go back to reference Brigino E, Haraguchi S, Koutsonikolis A, Cianciolo GJ, Owens U, Good RA, Day NK: Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway. Proc Natl Acad Sci USA. 1997, 94: 3178-3182. 10.1073/pnas.94.7.3178.PubMedCentralCrossRefPubMed Brigino E, Haraguchi S, Koutsonikolis A, Cianciolo GJ, Owens U, Good RA, Day NK: Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway. Proc Natl Acad Sci USA. 1997, 94: 3178-3182. 10.1073/pnas.94.7.3178.PubMedCentralCrossRefPubMed
34.
go back to reference Rosenberg S: Recent advances in the molecular biology of hepatitis C virus. J Mol Biol. 2001, 313: 451-464. 10.1006/jmbi.2001.5055.CrossRefPubMed Rosenberg S: Recent advances in the molecular biology of hepatitis C virus. J Mol Biol. 2001, 313: 451-464. 10.1006/jmbi.2001.5055.CrossRefPubMed
35.
go back to reference Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R, Budkowska A: Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol. 2001, 75: 8240-8250. 10.1128/JVI.75.17.8240-8250.2001.PubMedCentralCrossRefPubMed Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R, Budkowska A: Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol. 2001, 75: 8240-8250. 10.1128/JVI.75.17.8240-8250.2001.PubMedCentralCrossRefPubMed
36.
go back to reference Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM: Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science. 1999, 285: 107-110. 10.1126/science.285.5424.107.CrossRefPubMed Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM: Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science. 1999, 285: 107-110. 10.1126/science.285.5424.107.CrossRefPubMed
37.
go back to reference Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M, Lemon SM: Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA. 2005, 102: 2992-2997. 10.1073/pnas.0408824102.PubMedCentralCrossRefPubMed Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M, Lemon SM: Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA. 2005, 102: 2992-2997. 10.1073/pnas.0408824102.PubMedCentralCrossRefPubMed
38.
go back to reference Foy E, Li K, Wang C, Sumpter R, Ikeda M, Lemon SM, Gale M: Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science. 2003, 300: 1145-1148. 10.1126/science.1082604.CrossRefPubMed Foy E, Li K, Wang C, Sumpter R, Ikeda M, Lemon SM, Gale M: Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science. 2003, 300: 1145-1148. 10.1126/science.1082604.CrossRefPubMed
39.
go back to reference Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, et al, et al.: Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med. 2002, 195: 35-41. 10.1084/jem.20011124.PubMedCentralCrossRefPubMed Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, et al, et al.: Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med. 2002, 195: 35-41. 10.1084/jem.20011124.PubMedCentralCrossRefPubMed
40.
go back to reference Tseng CT, Klimpel GR: Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med. 2002, 195: 43-49. 10.1084/jem.20011145.PubMedCentralCrossRefPubMed Tseng CT, Klimpel GR: Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med. 2002, 195: 43-49. 10.1084/jem.20011145.PubMedCentralCrossRefPubMed
41.
go back to reference Nattermann J, Nischalke HD, Hofmeister V, Ahlenstiel G, Zimmermann H, Leifeld L, Weiss EH, Sauerbruch T, Spengler U: The HLA-A2 restricted T cell epitope HCV core 35–44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am J Pathol. 2005, 166: 443-453.PubMedCentralCrossRefPubMed Nattermann J, Nischalke HD, Hofmeister V, Ahlenstiel G, Zimmermann H, Leifeld L, Weiss EH, Sauerbruch T, Spengler U: The HLA-A2 restricted T cell epitope HCV core 35–44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am J Pathol. 2005, 166: 443-453.PubMedCentralCrossRefPubMed
42.
go back to reference Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, Kasahara A, Hori M: Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol. 1999, 162: 5584-5591.PubMed Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, Kasahara A, Hori M: Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol. 1999, 162: 5584-5591.PubMed
43.
go back to reference Large MK, Kittlesen DJ, Hahn YS: Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J Immunol. 1999, 162: 931-938.PubMed Large MK, Kittlesen DJ, Hahn YS: Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J Immunol. 1999, 162: 931-938.PubMed
44.
go back to reference Bergqvist A, Sundstrom S, Dimberg LY, Gylfe E, Masucci MG: The hepatitis C virus core protein modulates T cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations. J Biol Chem. 2003, 278: 18877-18883. 10.1074/jbc.M300185200.CrossRefPubMed Bergqvist A, Sundstrom S, Dimberg LY, Gylfe E, Masucci MG: The hepatitis C virus core protein modulates T cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations. J Biol Chem. 2003, 278: 18877-18883. 10.1074/jbc.M300185200.CrossRefPubMed
45.
go back to reference Tsubouchi E, Akbar SM, Horiike N, Onji M: Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J Gastroenterol. 2004, 39: 754-762. 10.1007/s00535-003-1385-3.CrossRefPubMed Tsubouchi E, Akbar SM, Horiike N, Onji M: Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J Gastroenterol. 2004, 39: 754-762. 10.1007/s00535-003-1385-3.CrossRefPubMed
46.
go back to reference McGilvray ID, Serghides L, Kapus A, Rotstein OD, Kain KC: Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood. 2000, 96: 3231-3240.PubMed McGilvray ID, Serghides L, Kapus A, Rotstein OD, Kain KC: Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood. 2000, 96: 3231-3240.PubMed
47.
go back to reference Ockenhouse CF, Tandon NN, Magowan C, Jamieson GA, Chulay JD: Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science. 1989, 243: 1469-1471. 10.1126/science.2467377.CrossRefPubMed Ockenhouse CF, Tandon NN, Magowan C, Jamieson GA, Chulay JD: Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science. 1989, 243: 1469-1471. 10.1126/science.2467377.CrossRefPubMed
48.
go back to reference Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, Hazen SL: Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med. 2006, 203: 2613-2625. 10.1084/jem.20060370.PubMedCentralCrossRefPubMed Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, Hazen SL: Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med. 2006, 203: 2613-2625. 10.1084/jem.20060370.PubMedCentralCrossRefPubMed
49.
go back to reference Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med. 1995, 181: 1857-1862. 10.1084/jem.181.5.1857.CrossRefPubMed Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med. 1995, 181: 1857-1862. 10.1084/jem.181.5.1857.CrossRefPubMed
50.
go back to reference Fadok VA, Warner ML, Bratton DL, Henson PM: CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol. 1998, 161: 6250-6257.PubMed Fadok VA, Warner ML, Bratton DL, Henson PM: CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol. 1998, 161: 6250-6257.PubMed
51.
go back to reference Asch AS, Liu I, Briccetti FM, Barnwell JW, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M: Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Science. 1993, 262: 1436-1440. 10.1126/science.7504322.CrossRefPubMed Asch AS, Liu I, Briccetti FM, Barnwell JW, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M: Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Science. 1993, 262: 1436-1440. 10.1126/science.7504322.CrossRefPubMed
52.
go back to reference Tandon NN, Kralisz U, Jamieson GA: Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem. 1989, 264: 7576-7583.PubMed Tandon NN, Kralisz U, Jamieson GA: Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem. 1989, 264: 7576-7583.PubMed
53.
go back to reference Asch AS, Barnwell J, Silverstein RL, Nachman RL: Isolation of the thrombospondin membrane receptor. J Clin Invest. 1987, 79: 1054-1061. 10.1172/JCI112918.PubMedCentralCrossRefPubMed Asch AS, Barnwell J, Silverstein RL, Nachman RL: Isolation of the thrombospondin membrane receptor. J Clin Invest. 1987, 79: 1054-1061. 10.1172/JCI112918.PubMedCentralCrossRefPubMed
54.
go back to reference Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993, 268: 11811-11816.PubMed Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993, 268: 11811-11816.PubMed
55.
go back to reference Urban BC, Willcox N, Roberts DJ: A role for CD36 in the regulation of dendritic cell function. Proc Natl Acad Sci USA. 2001, 98: 8750-8755. 10.1073/pnas.151028698.PubMedCentralCrossRefPubMed Urban BC, Willcox N, Roberts DJ: A role for CD36 in the regulation of dendritic cell function. Proc Natl Acad Sci USA. 2001, 98: 8750-8755. 10.1073/pnas.151028698.PubMedCentralCrossRefPubMed
56.
go back to reference Doyen V, Rubio M, Braun D, Nakajima T, Abe J, Saito H, Delespesse G, Sarfati M: Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med. 2003, 198: 1277-1283. 10.1084/jem.20030705.PubMedCentralCrossRefPubMed Doyen V, Rubio M, Braun D, Nakajima T, Abe J, Saito H, Delespesse G, Sarfati M: Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med. 2003, 198: 1277-1283. 10.1084/jem.20030705.PubMedCentralCrossRefPubMed
57.
go back to reference Serghides L, Kain KC: Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. J Immunol. 2001, 166: 6742-6748.CrossRefPubMed Serghides L, Kain KC: Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. J Immunol. 2001, 166: 6742-6748.CrossRefPubMed
58.
go back to reference Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, et al, et al.: Binding of hepatitis C virus to CD81. Science. 1998, 282: 938-941. 10.1126/science.282.5390.938.CrossRefPubMed Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, et al, et al.: Binding of hepatitis C virus to CD81. Science. 1998, 282: 938-941. 10.1126/science.282.5390.938.CrossRefPubMed
59.
go back to reference von Hahn T, Lindenbach BD, Boullier A, Quehenberger O, Paulson M, Rice CM, McKeating JA: Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology. 2006, 43: 932-942. 10.1002/hep.21139.CrossRefPubMed von Hahn T, Lindenbach BD, Boullier A, Quehenberger O, Paulson M, Rice CM, McKeating JA: Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology. 2006, 43: 932-942. 10.1002/hep.21139.CrossRefPubMed
60.
go back to reference Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB: Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006, 12: 1301-1309. 10.1038/nm1492.PubMedCentralCrossRefPubMed Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB: Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006, 12: 1301-1309. 10.1038/nm1492.PubMedCentralCrossRefPubMed
61.
go back to reference Bansal AS, Bruce J, Hogan PG, Prichard P, Powell EE: Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-gamma is elevated in patients with hepatitis C infection. Clin Immunol Immunopathol. 1997, 84: 139-144. 10.1006/clin.1997.4371.CrossRefPubMed Bansal AS, Bruce J, Hogan PG, Prichard P, Powell EE: Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-gamma is elevated in patients with hepatitis C infection. Clin Immunol Immunopathol. 1997, 84: 139-144. 10.1006/clin.1997.4371.CrossRefPubMed
62.
go back to reference Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM: Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology. 1996, 24: 6-9. 10.1002/hep.510240102.CrossRefPubMed Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM: Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology. 1996, 24: 6-9. 10.1002/hep.510240102.CrossRefPubMed
63.
go back to reference Bozkaya H, Bozdayi AM, Aslan N, Turkay C, Sarioglu M, Cetinkaya H, Akdogan M, Cinar K, Erden E, Kose K, et al, et al.: Circulating IL-2 and IL-10 in chronic active hepatitis C with respect to the response to IFN treatment. Infection. 2000, 28: 309-313. 10.1007/s150100070025.CrossRefPubMed Bozkaya H, Bozdayi AM, Aslan N, Turkay C, Sarioglu M, Cetinkaya H, Akdogan M, Cinar K, Erden E, Kose K, et al, et al.: Circulating IL-2 and IL-10 in chronic active hepatitis C with respect to the response to IFN treatment. Infection. 2000, 28: 309-313. 10.1007/s150100070025.CrossRefPubMed
64.
go back to reference Nelson DR, Lauers GY, Lau JY, Davis GL: Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology. 2000, 118: 655-660. 10.1016/S0016-5085(00)70134-X.CrossRefPubMed Nelson DR, Lauers GY, Lau JY, Davis GL: Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology. 2000, 118: 655-660. 10.1016/S0016-5085(00)70134-X.CrossRefPubMed
65.
go back to reference Nelson DR, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu YL, Cabrera R, Liu C, Davis GL: Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology. 2003, 38: 859-868.CrossRefPubMed Nelson DR, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu YL, Cabrera R, Liu C, Davis GL: Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology. 2003, 38: 859-868.CrossRefPubMed
66.
go back to reference Paladino N, Fainboim H, Theiler G, Schroder T, Munoz AE, Flores AC, Galdame O, Fainboim L: Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J Virol. 2006, 80: 9144-9150. 10.1128/JVI.00339-06.PubMedCentralCrossRefPubMed Paladino N, Fainboim H, Theiler G, Schroder T, Munoz AE, Flores AC, Galdame O, Fainboim L: Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J Virol. 2006, 80: 9144-9150. 10.1128/JVI.00339-06.PubMedCentralCrossRefPubMed
67.
go back to reference Knapp S, Hennig BJ, Frodsham AJ, Zhang L, Hellier S, Wright M, Goldin R, Hill AV, Thomas HC, Thursz MR: Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics. 2003, 55: 362-369. 10.1007/s00251-003-0594-5.CrossRefPubMed Knapp S, Hennig BJ, Frodsham AJ, Zhang L, Hellier S, Wright M, Goldin R, Hill AV, Thomas HC, Thursz MR: Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics. 2003, 55: 362-369. 10.1007/s00251-003-0594-5.CrossRefPubMed
68.
go back to reference Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, Wood KC, Holmberg SD: Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2003, 36: 363-367. 10.1086/345953.CrossRefPubMed Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, Wood KC, Holmberg SD: Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2003, 36: 363-367. 10.1086/345953.CrossRefPubMed
69.
go back to reference Salmon-Ceron D, Lewden C, Morlat P, Bevilacqua S, Jougla E, Bonnet F, Heripret L, Costagliola D, May T, Chene G: Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005, 42: 799-805. 10.1016/j.jhep.2005.01.022.CrossRefPubMed Salmon-Ceron D, Lewden C, Morlat P, Bevilacqua S, Jougla E, Bonnet F, Heripret L, Costagliola D, May T, Chene G: Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005, 42: 799-805. 10.1016/j.jhep.2005.01.022.CrossRefPubMed
70.
go back to reference Puoti M, Spinetti A, Ghezzi A, Donato F, Zaltron S, Putzolu V, Quiros-Roldan E, Zanini B, Casari S, Carosi G: Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr. 2000, 24: 211-217.CrossRefPubMed Puoti M, Spinetti A, Ghezzi A, Donato F, Zaltron S, Putzolu V, Quiros-Roldan E, Zanini B, Casari S, Carosi G: Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr. 2000, 24: 211-217.CrossRefPubMed
71.
go back to reference Valdez H, Anthony D, Farukhi F, Patki A, Salkowitz J, Heeger P, Peterson DL, Post AB, Asaad R, Lederman MM: Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients. AIDS. 2000, 14: 2239-2246. 10.1097/00002030-200010200-00004.CrossRefPubMed Valdez H, Anthony D, Farukhi F, Patki A, Salkowitz J, Heeger P, Peterson DL, Post AB, Asaad R, Lederman MM: Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients. AIDS. 2000, 14: 2239-2246. 10.1097/00002030-200010200-00004.CrossRefPubMed
72.
go back to reference Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, McGowan K, Rosenberg ES, Lucas M, Klenerman P, Chung RT, et al, et al.: Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol. 2002, 76: 2817-2826. 10.1128/JVI.76.6.2817-2826.2002.PubMedCentralCrossRefPubMed Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, McGowan K, Rosenberg ES, Lucas M, Klenerman P, Chung RT, et al, et al.: Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol. 2002, 76: 2817-2826. 10.1128/JVI.76.6.2817-2826.2002.PubMedCentralCrossRefPubMed
73.
go back to reference Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med. 1991, 115: 700-704.CrossRefPubMed Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med. 1991, 115: 700-704.CrossRefPubMed
74.
go back to reference Landmann R, Knopf HP, Link S, Sansano S, Schumann R, Zimmerli W: Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun. 1996, 64: 1762-1769.PubMedCentralPubMed Landmann R, Knopf HP, Link S, Sansano S, Schumann R, Zimmerli W: Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun. 1996, 64: 1762-1769.PubMedCentralPubMed
Metadata
Title
Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals
Authors
Lisa Barrett
Maureen Gallant
Constance Howley
M Ian Bowmer
Geri Hirsch
Kevork Peltekian
Michael Grant
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2008
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-9-28

Other articles of this Issue 1/2008

BMC Immunology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.